
SI-BONE Inc (SIBN) Stock Forecast & Price Target
SI-BONE Inc (SIBN) Analyst Ratings
Bulls say
SI-BONE is expected to experience strong future growth with a successful first quarter, a hybrid sales model, and a partnership with SNN contributing to revenue growth. Proposed changes in the DRG system and the launch of a new product are also expected to drive future growth. With a recent slight decrease in estimated value and a focus on innovation and expansion, SIBN is recommended as a Buy with potential for sustainable revenue growth and profitability in the near and long term.
Bears say
SI-BONE is facing a negative outlook due to its high valuation, as its current trading multiple is significantly higher than its peers in the ortho and spine sector. Additionally, while the company's revenue and gross profit margins are expected to grow, its operating expenses remain high and may hinder its path to profitability. Furthermore, there is uncertainty surrounding the long-term impact of the COVID-19 pandemic on the medical device industry, casting doubt on the company's ability to sustain its current growth trajectory.
This aggregate rating is based on analysts' research of SI-BONE Inc and is not a guaranteed prediction by Public.com or investment advice.
SI-BONE Inc (SIBN) Analyst Forecast & Price Prediction
Start investing in SI-BONE Inc (SIBN)
Order type
Buy in
Order amount
Est. shares
0 shares